海思科医药集团股份有限公司 关于控股股东部分股份质押及质押展期的公告

Group 1 - The company has received notification from its controlling shareholder, Mr. Wang Junmin, regarding the pledge and extension of certain shares held by him [1] - The pledged shares do not bear significant obligations related to major asset restructuring or performance compensation [1] - As of the announcement date, the cumulative pledge situation of the shares held by the shareholder and their concerted parties is detailed [1] Group 2 - The announcement was made by the board of directors of the company on September 11, 2025 [2]